var data={"title":"Timothy grass pollen sublingual tablet: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Timothy grass pollen sublingual tablet: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/731531?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=timothy-grass-pollen-sublingual-tablet-patient-drug-information\" class=\"drug drug_patient\">see &quot;Timothy grass pollen sublingual tablet: Patient drug information&quot;</a> and <a href=\"topic.htm?path=timothy-grass-pollen-sublingual-tablet-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Timothy grass pollen sublingual tablet: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24757293\" class=\"block black-box-warn drugH1Div\"><span class=\"drugH1\">ALERT: US Boxed Warning</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Severe allergic reactions:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Grass pollen allergen extract can cause life-threatening allergic reactions such as anaphylaxis and severe laryngopharyngeal restriction. Do not administer to patients with severe, unstable, or uncontrolled asthma. Observe patients in the office for at least 30 minutes following the initial dose. Prescribe auto-injectable epinephrine, instruct and train patients on its appropriate use, and instruct patients to seek immediate medical care upon its use. Grass pollen allergen extract may not be suitable for patients with certain underlying medical conditions that may reduce their ability to survive a serious allergic reaction. Grass pollen allergen extract may not be suitable for patients who may be unresponsive to epinephrine or inhaled bronchodilators, such as those taking beta-blockers.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24751503\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Grastek</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24751504\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Grastek</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24540999\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Allergen-Specific Immunotherapy</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541021\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">Dosage strength expressed in Bioequivalent Allergy Units (BAU). <b>Note:</b> Initiate treatment &ge;12 weeks before expected onset of each pollen season and continue throughout pollen season. May be taken daily for 3 consecutive years (including intervals between grass pollen seasons). Safety and efficacy of initiating treatment during grass pollen season  or restarting treatment after missing a dose have not been established. In clinical trials, treatment interruptions &le;7 days were allowed.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Grass pollen-induced allergic rhinitis:</b> Adults &le;65 years: Sublingual: One tablet (2,800 BAU) once daily</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541020\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=timothy-grass-pollen-sublingual-tablet-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Timothy grass pollen sublingual tablet: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">Dosage strength expressed in Bioequivalent Allergy Units (BAU).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Grass pollen-induced allergic rhinitis:</b> Children &ge;5 years and Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541022\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541023\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24755666\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet Sublingual, Sublingual: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Grastek: 2800 bau [contains gelatin (fish)]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25045345\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24757709\" class=\"block meg drugH1Div\"><span class=\"drugH1\">Medication Guide and/or Vaccine Information Statement (VIS)</span>\n    <p style=\"text-indent:0em;display:inline\">An FDA-approved patient medication guide, which is available with the product information and at <a target=\"_blank\" href=\"http://www.fda.gov/biologicsbloodvaccines/allergenics/ucm393188.htm&amp;token=wG4167KRyI6uzClTElJKBNSYbUMbjZO0hkbw8K9kpTOkpeKQj+GgQ7F/cQ/V1C5iSMDxn8N+Tq6esjNf54dyEXlvdtYLWMCx/GiTRH7+aXQ=&amp;TOPIC_ID=95239\" target=\"_blank\">http://www.fda.gov/biologicsbloodvaccines/allergenics/ucm393188.htm</a>, must be dispensed with this medication.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541026\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">Sublingual: Administer first dose in a healthcare setting due to the potential for allergic reactions; monitor patient for 30 minutes after first dose. If well tolerated, subsequent doses may be taken at home; subsequent pediatric doses should be done under adult supervision. Remove sublingual tablet from blister unit with dry hands immediately prior to administration. Place tablet under tongue until completely dissolved (&ge;1 minute) and then swallow. Wash hands after handling tablet. Avoid food or beverage for 5 minutes following dissolution of tablet (to prevent the swallowing of allergen extract). Auto-injectable epinephrine should be made available to patients.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541003\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">\n      <b>Grass pollen-induced allergic rhinitis:</b> Immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for timothy grass or cross-reactive grass pollens in patients 5 through 65 years of age. Not indicated for the immediate relief of allergy symptoms.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24540994\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Grass Pollen Allergen Extract (Timothy Grass) may be confused with Grass Pollen Allergen Extract (5 Grass Extract)</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24763942\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">&gt;10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Pruritus of ear (7% to 13%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gastrointestinal: Oral itching (24% to 27%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hypersensitivity: Mouth edema (10% to 11%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Respiratory: Throat irritation (21% to 23%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cardiovascular: Chest discomfort (2%), lip edema (adults: 1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Central nervous system: Headache (2% to 3%), oral hypoesthesia (1% to 2%), fatigue (adults: 1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Tongue pruritus (6% to 9%), lip pruritus (children and adolescents: 3%), pruritus (adults: 2%), urticaria (2%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Endocrine &amp; metabolic: Palatal edema (adults: 1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Gastrointestinal: Oral paresthesia (5% to 10%), lip swelling (4% to 7%), oral mucosa erythema (2% to 5%), swollen tongue (3%), dyspepsia (adults: 2%), nausea (2%), oral discomfort (2%), dysphagia (1% to 2%), glossalgia (1%), glossitis (adults: 1%), stomatitis (1%), tongue disease (adults: 1%), abdominal pain (adults: &le;1%), gastroesophageal reflux disease (adults: &le;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ophthalmic: Eye pruritus (children and adolescents: 3%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Respiratory: Pharyngeal erythema (children and adolescents: 4%), oropharyngeal pain (2% to 4%), cough (children and adolescents: 3%), pharyngeal edema (3%), dry throat (adults: 2%), nasal congestion (children and adolescents: 2%), nasal discomfort (2%), sneezing (children and adolescents: 2%), dyspnea (1% to 2%), constriction of the pharynx (adults: 1%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Postmarketing and/or case reports: Anaphylactic shock, anaphylaxis, angioedema, cardiac rate disturbance, chest pressure, decrease in forced vital capacity, diarrhea, dizziness, drowsiness, dysarthria, eosinophilic esophagitis, exacerbation of asthma, exacerbation of ulcerative colitis, exercise-induced asthma, facial edema, facial erythema, foreign body sensation, hoarseness, hypersensitivity reaction, hyperventilation, hypotension, impaired consciousness, increased heart rate, laryngeal discomfort, laryngitis, local hypersensitivity reaction, neck edema, oral mucosa ulcer, oxygen saturation decreased, peak expiratory flow rate decreased, localized swelling (enlarged uvula), pneumonia, reduced forced expiratory volume, respiratory distress, skin rash, status asthmaticus, stridor, tremor, vomiting, wheezing</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541008\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hypersensitivity to any of the inactive ingredients (gelatin, mannitol, and sodium hydroxide) contained in this product or any other component of the formulation; severe, unstable or uncontrolled asthma; history of any severe systemic allergic reaction; history of any severe local reaction to sublingual allergen immunotherapy; history of eosinophilic esophagitis</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Canadian labeling:</i> Additional contraindications (not in US labeling): Unstable, severe chronic, or severe seasonal asthma (FEV<sub>1</sub> &lt;70% of predicted value in adults; &lt;80% in children); concomitant beta-blocker therapy; oral inflammation (eg, oral lichen planus, oral ulcerations, severe oral candidiasis, or dental extraction)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541010\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Esophagitis: Eosinophilic esophagitis has been reported with sublingual tablet immunotherapy; discontinue therapy in patients who experience severe or persistent gastroesophageal symptoms (eg, dysphagia, chest pain). Use is contraindicated in patients with a history of eosinophilic esophagitis.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hypersensitivity reactions <b>[US Boxed Warning]: Severe, life-threatening allergic reactions, including anaphylaxis and severe laryngopharyngeal restrictions, may occur.</b> Local reactions in the mouth or throat may occur; consider discontinuation in patients experiencing escalating and persistent adverse reactions in the mouth or throat. Increased risk of local or systemic adverse reactions may occur when given with concomitant allergen immunotherapy.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns: </i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Respiratory disease: <b>[US Boxed Warning]: Do not administer to patients with severe, unstable, or uncontrolled asthma;</b> use has not been studied in patients with moderate or severe asthma or in patients requiring daily medication.  Withhold treatment if patient is experiencing an acute asthma exacerbation. Re-evaluate patients with recurrent asthma exacerbations and consider discontinuation.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Vaccines: Effect of vaccination during therapy has not been evaluated.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Administration: <b>[US Boxed Warning]: Auto-injectable epinephrine should be prescribed to patients; instruct patients on appropriate use and to obtain immediate medical care upon its use.</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate patient selection: <b>[US Boxed Warning]: Use may not be suitable for patients with conditions that may reduce their ability to survive a serious allergic reaction,</b> including but not limited to compromised lung function (either chronic or acute) and cardiovascular conditions (eg, unstable angina, recent MI, arrhythmia, and uncontrolled hypertension).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: <b>[US Boxed Warning]: Use may not be suitable for patients who may be unresponsive to epinephrine or inhaled bronchodilators due to concomitant drug therapy.</b> The effect of epinephrine may be potentiated or inhibited by the following medications: beta blockers, alpha blockers, ergot alkaloids, tricyclic antidepressants, levothyroxine, monoamine oxidase inhibitors, antihistamines, cardiac glycosides, and diuretics.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Monitoring: <b>[US Boxed Warning]: Monitor all patients for at least 30 minutes after initial dose</b> in a health care setting under the supervision of a physician with experience in the diagnosis and treatment of allergic diseases. Each subsequent dose in pediatric patients should be done under direct adult supervision.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Oral inflammation/wounds: Discontinue therapy to allow for complete healing of the oral cavity due to oral inflammation (eg, oral lichen planus, mouth ulcers, or thrush) or oral wounds following oral surgery or dental extraction.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24674132\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24674129\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=95239&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24751505\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;margin-left:0em;display:inline\">B (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541004\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have not been observed in animal reproduction studies.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541007\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">It is not known if grass pollen allergen extract is excreted in breast milk. The manufacturer recommends that caution be exercised when administering to nursing women. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541028\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Signs/symptoms of hypersensitivity; monitor patients for at least 30 minutes after administration of first dose.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24541014\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;\">Grass pollen allergen extract contains extract from timothy grass. While the exact mechanism has not been fully elucidated, specific immunotherapy (SIT) may act by inducing a switch from T helper 2 cell response (Th2) to T helper 1 cell (Th1) response resulting in decreased interleukin-4 (IL-4) and interleukin-5 (IL-5) and increased interleukin-10 (IL-10), production of IgG-blocking antibodies that compete with IgE antibodies for allergen binding, proliferation of regulatory T lymphocytes and cytokines, and decreases in mast cells, eosinophils, and early- and late-phase allergic responses (Leith 2006).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25211459\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Sublingual</b> (Grastek Sublingual)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">2800 bau (10): $116.54</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Didier A, Worm M, Horak F, et al, &ldquo;Sustained 3-year efficacy of pre- and Coseasonal 5-Grass-Pollen Sublingual Immunotherapy Tablets In Patients With Grass Pollen-Induced Rhinoconjunctivitis,&rdquo; <i>J Allergy Clin Immunol</i>, 2011, 128(3):559-66.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/timothy-grass-pollen-sublingual-tablet-drug-information/abstract-text/21802126/pubmed\" target=\"_blank\" id=\"21802126\">21802126</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Epstein TG, Calabria C, Cox LS, Dreborg S. Current evidence on safety and practical considerations for administration of sublingual allergen immunotherapy (SLIT) in the United States.<i> J Allergy Clin Immunol Pract</i>. 2017;5(1):34-40.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/timothy-grass-pollen-sublingual-tablet-drug-information/abstract-text/27815065/pubmed\" target=\"_blank\" id=\"27815065\">27815065</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Grastek (timothy grass pollen allergen extract) [prescribing information]. Whitehouse Station, NJ: Merck &amp; Co, Inc; September 2016.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Grastek (timothy grass pollen allergen extract) [product monograph]. Kirkland, Quebec, Canada: Merck Canada Inc; May 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Greenhawt M, Oppenheimer J, Nelson M, et al. Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update. <i>Ann Allergy Asthma Immunol</i>. 2017;118(3):276-282.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/timothy-grass-pollen-sublingual-tablet-drug-information/abstract-text/28284533/pubmed\" target=\"_blank\" id=\"28284533\">28284533</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Leith E, Bowen T, Butchey J, et al, &ldquo;Consensus Guidelines on Practical Issues of Immunotherapy-Canadian Society of Allergy and Clinical Immunology (CSACI),&rdquo; <i>Allergy Asthma Clin Immunol</i>, 2006, 2(2):47-61.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/timothy-grass-pollen-sublingual-tablet-drug-information/abstract-text/20525157/pubmed\" target=\"_blank\" id=\"20525157\">20525157</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wahn U, Tabar A, Kuna P, et al, &ldquo;Efficacy and Safety of 5-Grass-Pollen Sublingual Immunotherapy Tablets in Pediatric Allergic Rhinoconjunctivitis,&rdquo; <i>J Allergy Clin Immunol</i>, 2009, 123(1):160-6.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/timothy-grass-pollen-sublingual-tablet-drug-information/abstract-text/19046761/pubmed\" target=\"_blank\" id=\"19046761\">19046761</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 95239 Version 39.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"ALERT: US Boxed Warning\" href=\"#F24757293\" class=\"outlineLink\">ALERT: US Boxed Warning</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F24751503\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F24751504\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F24540999\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F24541021\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F24541020\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F24541022\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F24541023\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F24755666\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F25045345\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Medication Guide and/or Vaccine Information Statement (VIS)\" href=\"#F24757709\" class=\"outlineLink\">Medication Guide and/or Vaccine Information Statement (VIS)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F24541026\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F24541003\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F24540994\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F24763942\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F24541008\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F24541010\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F24674132\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F24674129\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F24751505\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F24541004\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F24541007\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F24541028\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F24541014\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F25211459\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/95239|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=timothy-grass-pollen-sublingual-tablet-patient-drug-information\" class=\"drug drug_patient\">Timothy grass pollen sublingual tablet: Patient drug information</a></li><li><a href=\"topic.htm?path=timothy-grass-pollen-sublingual-tablet-pediatric-drug-information\" class=\"drug drug_pediatric\">Timothy grass pollen sublingual tablet: Pediatric drug information</a></li></ul></div></div>","javascript":null}